REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Stenocoat Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Engineering Services | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services
Full name: Stenocoat Sp. z o.o. Profile Updated: May 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Stenocoat Sp. z o.o is a company that develops coatings for urological and cardiological medical devices. They use knowledge from experts in Medicine, Biomedical Engineering, Surface engineering, Biotechnology, Chemical engineering, and Organic chemistry to meet the specific needs and requirements of medical device manufacturers.

Headquarters
Ul. Symboliczna 3/92
Warsaw; Mazowieckie; Postal Code: 01-252

Contact Details: Purchase the Stenocoat Sp. z o.o. report to view the information.

Website: http://www.stenocoat.com

Basic Information
Outstanding Shares:
Purchase the Stenocoat Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Stenocoat Sp. z o.o. report to view the information.
Incorporation Date:
January 23, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Stenocoat Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-103.24%▼
Net Profit (Loss) for the Period
-103.24%▼
Total assets
-17.89%▼
Total equity
-17.77%▼
Return on Equity (ROE)
-12.87%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo